← Back to Search

Dietary intervention and nutritional supplements (group A) for Concussion

N/A

Waitlist Available

Led By Stephanie Ward Chiasson, PhD, RD

Research Sponsored by Universite de Moncton

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and endpoint (week 8)

Awards & highlights

Study Summary

This trial aims to assess the impact of dietary & nutritional interventions on post-concussion symptoms. Patients will be randomly assigned to receive different treatments. Symptoms will be monitored over 8 weeks.

Eligible Conditions

Concussion

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and endpoint (week 8)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and endpoint (week 8)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and endpoint (week 8) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Interventional procedure

Secondary outcome measures

Interventional procedure

Change from baseline in vestibular ocular motor at the end of the intervention

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Physiotherapy treatment (control group)Experimental Treatment1 Intervention

Patients in the control group will receive physiotherapy treatments over eight weeks.

Group II: Dietary intervention and nutritional supplements (group A)Experimental Treatment3 Interventions

Patients in group A will receive four consultations with a dietitian over eight weeks, in addition to conventional physiotherapy treatments. These patients will receive nutritional counselling and omega-3 (2500mg/day), vitamin D (2000 IU/day) and creatine monohydrate (10mg/day) supplements prescribed by their doctor.

Group III: Nutritional supplements (group B)Active Control2 Interventions

Patients in group B will be prescribed omega-3 (2500mg/day), vitamin D (2000 IU/day) and creatine monohydrate (10mg/day) supplements and receive physiotherapy treatments over eight weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

New Brunswick Health Research FoundationOTHER

10 Previous Clinical Trials

5,875 Total Patients Enrolled

Universite de MonctonLead Sponsor

9 Previous Clinical Trials

5,101 Total Patients Enrolled

Stephanie Ward Chiasson, PhD, RDPrincipal InvestigatorUniversite de Moncton

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for this experiment?

"No, this study is no longer seeking patients according to the latest information available on clinicaltrials.gov. The trial was first posted on October 1st, 2022 and last updated 17 days later. However, there are nearly a thousand other trials that are still recruiting patients."

Answered by AI

Recent research and studies

British Journal of Sports MedicineJournal

Consensus Statement on Concussion in Sport—the 5<sup>th</sup>international Conference on Concussion in Sport Held in Berlin, October 2016

McCrory, Paul, Willem Meeuwisse, Jiří Dvorak, Mark Aubry, Julian Bailes, Steven Broglio, Robert C Cantu, et al.. 2017. “Consensus Statement on Concussion in Sport—the 5thinternational Conference on Concussion in Sport Held in Berlin, October 2016”. British Journal of Sports Medicine. BMJ. doi:10.1136/bjsports-2017-097699.

The American Journal of Sports MedicineJournal

A Brief Vestibular/ocular Motor Screening (VOMS) Assessment to Evaluate Concussions

Mucha, Anne, Michael W. Collins, R.J. Elbin, Joseph M. Furman, Cara Troutman-Enseki, Ryan M. DeWolf, Greg Marchetti, and Anthony P. Kontos. 2014. “A Brief Vestibular/ocular Motor Screening (VOMS) Assessment to Evaluate Concussions”. The American Journal of Sports Medicine. SAGE Publications. doi:10.1177/0363546514543775.

JAMA NeurologyJournal

Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults

Miller, Joshua W., Danielle J. Harvey, Laurel A. Beckett, Ralph Green, Sarah Tomaszewski Farias, Bruce R. Reed, John M. Olichney, Dan M. Mungas, and Charles DeCarli. 2015. “Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults”. JAMA Neurology. American Medical Association (AMA). doi:10.1001/jamaneurol.2015.2115.

JamaJournal